Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Sames C
Grechishnikova D
If Foundayo's clinical outcomes hold up in real-world use (the Phase 3 ATTAIN-1 trial showed 11.2% mean weight loss at 72 weeks on the 36 mg dose, or 12.4% among participants who stayed on treatment), it could become the go-to affordable GLP-1 option and put downward pressure on Wegovy and Zepbound pricing
Still, doctors recommend reviewing all medications before starting Foundayo, because it can affect how some other drugs are absorbed
US$ 24.74
US$ 27.19
US$ 25.04
